KINDAL DELAY: Open Payments
NPI 1831326982 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 37 payments from 13 companies in 2025. Trend: 2023 $367 · 2024 $309 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| PFIZER INC. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Inspire Medical Systems, Inc. | 1 | $58 |
| Amgen Inc. | 3 | $50 |
| Exact Sciences Corporation | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| SANOFI-AVENTIS U.S. LLC | 2 | $29 |
Products named: JARDIANCE, MOUNJARO, ELIQUIS, INSPIRE, FARXIGA, The Cologuard Plus Collection Kit, Kerendia, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
